
Please try another search
By Davit Kirakosyan
Citi downgraded Mirati Therapeutics (NASDAQ:MRTX) to Neutral from Buy and lowered its price target to $53.00 from $121.00. Shares plunged more than 52% in the last 3 days after the company’s lung cancer therapy (adagrasib) data disappointed investors.
Baird downgraded Salesforce Inc (NYSE:CRM) to Neutral from Outperform and lowered its price target to $150.00 from $200.00 given the tough macro environment, seat-based software pressure, and the recent executive departures.
JPMorgan downgraded Sinclair Broadcast Group Inc (NASDAQ:SBGI) to Underweight from Neutral and cut its price target to $16.00 from $25.00. Shares closed more than 3% lower today.
BTIG downgraded Unity Software Inc (NYSE:U) to Neutral from Buy.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.